lg 100268 has been researched along with Carcinoma, Embryonal in 1 studies
LG 100268: a retinoid X receptor (RXR) selective compound; structure given in first source
Carcinoma, Embryonal: A highly malignant, primitive form of carcinoma, probably of germinal cell or teratomatous derivation, usually arising in a gonad and rarely in other sites. It is rare in the female ovary, but in the male it accounts for 20% of all testicular tumors. (From Dorland, 27th ed & Holland et al., Cancer Medicine, 3d ed, p1595)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, Y | 1 |
| Glozak, MA | 1 |
| Smith, SM | 1 |
| Rogers, MB | 1 |
1 other study available for lg 100268 and Carcinoma, Embryonal
| Article | Year |
|---|---|
The expression and activity of D-type cyclins in F9 embryonal carcinoma cells: modulation of growth by RXR-selective retinoids.
Topics: Alitretinoin; Animals; Antineoplastic Agents; Benzoates; Biomarkers; Carcinoma, Embryonal; Cell Adhe | 1999 |